Auto - Parts
Compare Stocks
4 / 10Stock Comparison
DORM vs BWA vs LEA vs DAN
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Parts
Auto - Parts
DORM vs BWA vs LEA vs DAN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Auto - Parts | Auto - Parts | Auto - Parts | Auto - Parts |
| Market Cap | $3.72B | $12.05B | $6.85B | $4.62B |
| Revenue (TTM) | $2.15B | $14.33B | $23.52B | $0.00 |
| Net Income (TTM) | $190M | $362M | $528M | $-33M |
| Gross Margin | 40.7% | 18.9% | 5.3% | 8.0% |
| Operating Margin | 15.6% | 9.6% | 3.2% | 2.8% |
| Forward P/E | 15.0x | 11.3x | 9.4x | 13.5x |
| Total Debt | $633M | $4.18B | $4.10B | $3.52B |
| Cash & Equiv. | $49M | $2.31B | $1.03B | $476M |
DORM vs BWA vs LEA vs DAN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
| BorgWarner Inc. (BWA) | 100 | 205.7 | +105.7% |
| Lear Corporation (LEA) | 100 | 127.6 | +27.6% |
| Dana Incorporated (DAN) | 100 | 273.4 | +173.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DORM vs BWA vs LEA vs DAN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DORM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
- Beta 0.85, current ratio 3.09x
- 6.0% revenue growth vs DAN's -27.1%
BWA lags the leaders in this set but could rank higher in a more targeted comparison.
LEA is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 0 yrs, beta 1.14, yield 2.3%
- PEG 0.37 vs DORM's 1.00
- Lower P/E (9.4x vs 13.5x)
- 2.3% yield, vs BWA's 0.9%, (1 stock pays no dividend)
DAN is the clearest fit if your priority is long-term compounding.
- 210.7% 10Y total return vs DORM's 129.7%
- +139.1% vs DORM's +0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs DAN's -27.1% | |
| Value | Lower P/E (9.4x vs 13.5x) | |
| Quality / Margins | 8.8% margin vs DAN's 1.1% | |
| Stability / Safety | Beta 0.85 vs DAN's 1.37, lower leverage | |
| Dividends | 2.3% yield, vs BWA's 0.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +139.1% vs DORM's +0.5% | |
| Efficiency (ROA) | 7.6% ROA vs DAN's -0.4%, ROIC 13.9% vs 4.0% |
DORM vs BWA vs LEA vs DAN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DORM vs BWA vs LEA vs DAN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DORM leads in 2 of 6 categories
LEA leads 1 • DAN leads 1 • BWA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DORM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LEA and DAN operate at a comparable scale, with $23.5B and $0 in trailing revenue. DORM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to DAN's 1.1%. On growth, LEA holds the edge at +4.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $14.3B | $23.5B | $0 |
| EBITDAEarnings before interest/tax | $377M | $1.9B | $1.2B | $354M |
| Net IncomeAfter-tax profit | $190M | $362M | $528M | -$33M |
| Free Cash FlowCash after capex | $71M | $1.6B | $732M | $298M |
| Gross MarginGross profit ÷ Revenue | +40.7% | +18.9% | +5.3% | +8.0% |
| Operating MarginEBIT ÷ Revenue | +15.6% | +9.6% | +3.2% | +2.8% |
| Net MarginNet income ÷ Revenue | +8.8% | +2.5% | +2.2% | +1.1% |
| FCF MarginFCF ÷ Revenue | +3.3% | +11.1% | +3.1% | +4.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.2% | +0.5% | +4.7% | -3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.5% | +61.1% | +124.2% | -120.0% |
Valuation Metrics
LEA leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 16.6x trailing earnings, LEA trades at a 69% valuation discount to DAN's 54.0x P/E. Adjusting for growth (PEG ratio), LEA offers better value at 0.65x vs DORM's 1.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.7B | $12.0B | $6.8B | $4.6B |
| Enterprise ValueMkt cap + debt − cash | $4.3B | $13.9B | $9.9B | $7.7B |
| Trailing P/EPrice ÷ TTM EPS | 18.75x | 45.45x | 16.60x | 54.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.05x | 11.28x | 9.39x | 13.54x |
| PEG RatioP/E ÷ EPS growth rate | 1.25x | — | 0.65x | — |
| EV / EBITDAEnterprise value multiple | 10.41x | 6.81x | 6.10x | 13.44x |
| Price / SalesMarket cap ÷ Revenue | 1.75x | 0.84x | 0.29x | 0.62x |
| Price / BookPrice ÷ Book value/share | 2.59x | 2.24x | 1.39x | 5.23x |
| Price / FCFMarket cap ÷ FCF | 49.18x | 10.22x | 12.99x | 15.51x |
Profitability & Efficiency
DORM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DORM delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-2 for DAN. DORM carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to DAN's 3.82x. On the Piotroski fundamental quality scale (0–9), BWA scores 8/9 vs DAN's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.1% | +6.2% | +11.1% | -2.5% |
| ROA (TTM)Return on assets | +7.6% | +2.6% | +4.0% | -0.4% |
| ROICReturn on invested capital | +13.9% | +12.9% | +9.7% | +4.0% |
| ROCEReturn on capital employed | +18.5% | +12.7% | +11.5% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.43x | 0.74x | 0.79x | 3.82x |
| Net DebtTotal debt minus cash | $584M | $1.9B | $3.1B | $3.0B |
| Cash & Equiv.Liquid assets | $49M | $2.3B | $1.0B | $476M |
| Total DebtShort + long-term debt | $633M | $4.2B | $4.1B | $3.5B |
| Interest CoverageEBIT ÷ Interest expense | 8.24x | 10.46x | 7.55x | 0.77x |
Total Returns (Dividends Reinvested)
DAN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DAN five years ago would be worth $13,642 today (with dividends reinvested), compared to $7,682 for LEA. Over the past 12 months, DAN leads with a +139.1% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors DAN at 36.4% vs LEA's 4.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.3% | +25.1% | +14.7% | +39.0% |
| 1-Year ReturnPast 12 months | +0.5% | +94.2% | +61.3% | +139.1% |
| 3-Year ReturnCumulative with dividends | +41.6% | +50.8% | +13.4% | +153.6% |
| 5-Year ReturnCumulative with dividends | +19.2% | +28.7% | -23.2% | +36.4% |
| 10-Year ReturnCumulative with dividends | +129.7% | +114.1% | +38.9% | +210.7% |
| CAGR (3Y)Annualised 3-year return | +12.3% | +14.7% | +4.3% | +36.4% |
Risk & Volatility
Evenly matched — DORM and LEA each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than DAN's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LEA currently trades 94.7% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.85x | 1.01x | 1.14x | 1.37x |
| 52-Week HighHighest price in past year | $166.89 | $70.08 | $142.84 | $39.56 |
| 52-Week LowLowest price in past year | $98.44 | $29.41 | $85.04 | $14.48 |
| % of 52W HighCurrent price vs 52-week peak | +74.6% | +83.0% | +94.7% | +87.4% |
| RSI (14)Momentum oscillator 0–100 | 71.2 | 65.7 | 67.4 | 49.3 |
| Avg Volume (50D)Average daily shares traded | 273K | 2.3M | 558K | 1.1M |
Analyst Outlook
Evenly matched — DORM and LEA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DORM as "Buy", BWA as "Buy", LEA as "Hold", DAN as "Buy". Consensus price targets imply 18.3% upside for BWA (target: $69) vs -6.4% for LEA (target: $127). For income investors, LEA offers the higher dividend yield at 2.27% vs BWA's 0.95%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $140.00 | $68.80 | $126.57 | $37.00 |
| # AnalystsCovering analysts | 16 | 38 | 31 | 24 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% | +2.3% | +1.1% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.55 | $3.08 | $0.39 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +4.2% | +4.7% | +14.1% |
DORM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LEA leads in 1 (Valuation Metrics). 2 tied.
DORM vs BWA vs LEA vs DAN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DORM or BWA or LEA or DAN a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus -27. 1% for Dana Incorporated (DAN). Lear Corporation (LEA) offers the better valuation at 16. 6x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate Dorman Products, Inc. (DORM) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DORM or BWA or LEA or DAN?
On trailing P/E, Lear Corporation (LEA) is the cheapest at 16.
6x versus Dana Incorporated at 54. 0x. On forward P/E, Lear Corporation is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Lear Corporation wins at 0. 37x versus Dorman Products, Inc. 's 1. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DORM or BWA or LEA or DAN?
Over the past 5 years, Dana Incorporated (DAN) delivered a total return of +36.
4%, compared to -23. 2% for Lear Corporation (LEA). Over 10 years, the gap is even starker: DAN returned +210. 7% versus LEA's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DORM or BWA or LEA or DAN?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus Dana Incorporated's 1. 37β — meaning DAN is approximately 61% more volatile than DORM relative to the S&P 500. On balance sheet safety, Dorman Products, Inc. (DORM) carries a lower debt/equity ratio of 43% versus 4% for Dana Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — DORM or BWA or LEA or DAN?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus -27. 1% for Dana Incorporated (DAN). On earnings-per-share growth, the picture is similar: Dana Incorporated grew EPS 264. 1% year-over-year, compared to -14. 7% for BorgWarner Inc.. Over a 3-year CAGR, DORM leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DORM or BWA or LEA or DAN?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus 1. 1% for Dana Incorporated — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 2. 8% for DAN. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DORM or BWA or LEA or DAN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Lear Corporation (LEA) is the more undervalued stock at a PEG of 0. 37x versus Dorman Products, Inc. 's 1. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Lear Corporation (LEA) trades at 9. 4x forward P/E versus 15. 0x for Dorman Products, Inc. — 5. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BWA: 18. 3% to $68. 80.
08Which pays a better dividend — DORM or BWA or LEA or DAN?
In this comparison, LEA (2.
3% yield), DAN (1. 1% yield), BWA (0. 9% yield) pay a dividend. DORM does not pay a meaningful dividend and should not be held primarily for income.
09Is DORM or BWA or LEA or DAN better for a retirement portfolio?
For long-horizon retirement investors, BorgWarner Inc.
(BWA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 0. 9% yield, +114. 1% 10Y return). Both have compounded well over 10 years (BWA: +114. 1%, DORM: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DORM and BWA and LEA and DAN?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DORM is a small-cap quality compounder stock; BWA is a mid-cap quality compounder stock; LEA is a small-cap deep-value stock; DAN is a small-cap quality compounder stock. BWA, LEA, DAN pay a dividend while DORM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.